The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review

• Published in: Addiction science & clinical practice Vol. 16; no. 1; pp. 62 - 25
• Main Authors: Frost, Madeline C., Lampert, Hannah, Tsui, Judith I., Iles-Shih, Matthew D., Williams, Emily C.
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 11.10.2021; BioMed Central; BMC
• Subjects: Abstinence; Agonists; Amphetamine; Amphetamines; Analysis; Bias; Buprenorphine; Buprenorphine - therapeutic use; COVID-19; Drug use; Drugs; Extraction; Heroin; Humans; Implants; Medical screening; Methadone; Methadone - therapeutic use; Methamphetamine; Methamphetamine - adverse effects; Multiple drugs; Naltrexone; Narcotics; Opiate Substitution Treatment; Opioid agonist; Opioid use disorder; Opioid-Related Disorders - drug therapy; Opioid-Related Disorders - epidemiology; Opioids; Overdose; Prevention; Retention; Review; Risk assessment; Subject headings; Substance abuse; Substance use disorder; Systematic review; Treatment methods; United States > US; Amphetamine; Buprenorphine; Methamphetamine; Polysubstance use; Methadone; Naltrexone; Opioid use disorder; Opioid agonist

Methamphetamine/amphetamine use has sharply increased among people with opioid use disorder (OUD). It is therefore important to understand whether and how use of these substances may impact receipt of, and outcomes associated with, medications for OUD (MOUD). This systematic review identified studie...